KEY LARGO, Fla., April 3 /PRNewswire-FirstCall/ -- The American Microcap Institute (AMI), the leading online resource for microcap investors and a division of Hawk Associates Inc., announced today that it has initiated coverage of NeoGenomics, Inc. with a long-term accumulate recommendation. NeoGenomics is an independent medical laboratory company specializing in genetic testing for cancer. The analyst report can be accessed from the AMI website, http://www.americanmicrocaps.com .
The report, written by Senior Analyst Cale Smith, provides an overview of NeoGenomics, the range of testing services it offers and the favorable economics of genetic testing. The genetic testing market and NeoGenomics’ business strategy are detailed in the report, which provides a complete analysis of the company’s financial position and the current investment opportunity.
Hawk Associates CEO Frank Hawkins said, “This is the first analyst report the American Microcap Institute has produced. It is an excellent evaluation of a rapidly emerging company in an important and growing industry. We believe this report provides a critical means of communicating the company’s value to the market. With the vast majority of microcap stocks overlooked by Wall Street, we feel our research reports can help promising young companies like NeoGenomics receive the attention they deserve from sophisticated and serious investors. We invite all investors to download this report, which is available free of charge at the American Microcap Institute.”
About NeoGenomics, Inc.
NeoGenomics, Inc. is a CLIA-certified medical laboratory specializing in cancer genetic testing services including cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry and molecular tests. The company provides a range of gene-based testing services to oncologists, urologists, pathologists, hospitals and other laboratories from its headquarters in Ft. Myers, Fla. The company differentiates itself through its focus on genetic cancer tests, industry-leading turnaround times and a high level of customer service. NeoGenomics is the only pure-play publicly traded independent genetic testing lab. For additional information about NeoGenomics, visit http://www.neogenomics.org .
An investment profile about NeoGenomics may be found at http://www.americanmicrocaps.com/ngnm/profile.pdf .
To sign up for free e-mail alert notifications about NeoGenomics, Inc., visit http://www.americanmicrocaps.com .
About the American Microcap Institute
The American Microcap Institute (AMI), a subsidiary of Hawk Associates, is dedicated to providing investors with timely and accurate information on companies trading under $5. The AMI website provides investors with a free stock watch list and information about featured microcaps, company headlines, 20-minute-delayed Level II price quotes, e-mail alerts, CEO interviews and research reports. No registration is required to access the site. For more information, visit http://www.americanmicrocaps.com .
About Hawk Associates Inc.
Hawk Associates Inc. is one of America’s leading full-service providers of investor relations and media services to microcap and small cap companies. Known for integrity as well as aggressive and dedicated service, Hawk offers Fortune 200 global experience and national award-winning expertise in providing a sustainable and effective interface with Wall Street. Hawk’s state-of-the-art websites, leading-edge technology and well-established Wall Street relationships enable the company’s clients to reach investors with their stories in a credible and effective manner.
Hawk Associates specializes in helping emerging and unknown companies develop their messages and implement successful IR programs to stand out among the more than 5,000 small and microcap companies on Wall Street. The company has clients throughout the United States, Canada and China.
For more information, contact Frank Hawkins or Julie Marshall at (305) 451-1888 or visit http://www.hawkassociates.com and http://www.americanmicrocaps.com .
Hawk Associates Inc.
CONTACT: Frank Hawkins or Julie Marshall, both of Hawk Associates,+1-305-451-1888, or operations@americanmicrocaps.com